ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Imaging-proteomic analysis for prediction of neoadjuvant chemotherapy responses in patients with breast cancer

Duan, Jingxian; Zhao, Yuanshen; Sun, Qiuchang; Liang, Dong; Liu, Zaiyi; Chen, Xin*; Li, Zhi-Cheng*广东省人民医院; 中国科学院; 1
Cancer Medicine2023-12DOI: 10.1002/cam4.6704
7阅读
引用收藏
分享

摘要

Background: Optimizing patient selection for neoadjuvant chemotherapy in patients with breast cancer remains an unmet clinical need. Quantitative features from medical imaging were reported to be predictive of treatment responses. However, the biologic meaning of these latent features is poorly understood, preventing the clinical use of such noninvasive imaging markers. The study aimed to develop a deep learning signature (DLS) from pretreatment magnetic resonance imaging (MRI) for predicting responses to neoadjuvant chemotherapy in patients with breast cancer and to further investigate the biologic meaning of the DLS by identifying its underlying pathways using paired MRI and proteomic sequencing data.Methods: MRI-based DLS was constructed (radiogenomic training dataset, n = 105) and validated (radiogenomic validation dataset, n = 26) for the prediction of pathologic complete response (pCR) to neoadjuvant chemotherapy. Proteomic sequencing revealed biological functions facilitating pCR (n = 139). Their associations with DLS were uncovered by radiogenomic analysis.Results: The DLS achieved a prediction accuracy of 0.923 with an AUC of 0.958, higher than the performance of the model trained by transfer learning. Cellular membrane formation, endocytosis, insulin-like growth factor binding, protein localization to membranes, and cytoskeleton-dependent trafficking were differentially regulated in patients showing pCR. Oncogenic signaling pathways, features correlated with human phenotypes, and features correlated with general biological processes were significantly correlated with DLS in both training and validation dataset (p.adj < 0.05).Conclusions: Our study offers a biologically interpretable DLS for the prediction of pCR to neoadjuvant chemotherapy in patients with breast cancer, which may guide personalized medication.

学科与关键词

关键词
breast cancerdeep learningneoadjuvant chemotherapypathologic complete responseRadiogenomics
相关
加载中…
  • Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
    Choi, Joon Ho; Kim, Hyun-Ah*; Kim, Wook; Lim, Ilhan; Lee, Inki; Byun, Byung Hyun; Noh, Woo Chul; Seong, Min-Ki; Lee, Seung-Sook; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo; Woo, Sang-Keun*Scientific Reports, 2020, 10(1): 21149.被引 56
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
  • MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
    Shi, Zhenwei; Huang, Xiaomei; Cheng, Ziliang; Xu, Zeyan; Lin, Huan; Liu, Chen; Chen, Xiaobo; Liu, Chunling; Liang, Changhong; Lu, Cheng; Cui, Yanfen; Han, Chu; Qu, Jinrong; Shen, Jun; Liu, Zaiyi*RADIOLOGY, 2023, 308(1): e222830.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2023-12
卷期
第 12 卷, 第 23 期
页码
21256-21269
DOI
10.1002/cam4.6704
语言
ENGLISH
成果收录
SCIE
资助标注
Not applicable.

作者

  • D

    Duan, Jingxian (第一作者)

    chinese acad sci

  • Z

    Zhao, Yuanshen

    chinese acad sci

查看全部 7 位作者收起作者
  • S

    Sun, Qiuchang

    chinese acad sci

  • L

    Liang, Dong

    chinese acad sci

  • L

    Liu, Zaiyi

    guangdong prov peoples hosp

  • C

    Chen, Xin (通讯)

    1

  • L

    Li, Zhi-Cheng (通讯)

    chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417